Progressive facial hemiatrophy (PFH) is a ubiquitous disease, characterized by hyperpigmentation of the skin followed by unilateral craniofacial atrophy of subcutaneous tissues, including fat, muscle and bone. Hereditary factors have been postulated to be involved in the aetiology of PFH. Yet, the occurrence of PFH in one of two identical male twins reported here makes this possibility unlikely. PFH usually occurs in the first two decades of life, and the clinical presentation resembles linear scleroderma. PFH may be complicated by autoimmune, neurological, ocular and dental disorders. Management of PFH comprises a long term follow-up of somatic disorders, and prevention of psychological problems. Treatment of PFH is symptomatic and consist...
An asymmetric variation of facial structures is commonly seen in the general population. Hemimandibu...
Progressive Hemifacial atrophy (Parry-Romberg disease) is a rare condition affecting the face. It co...
A case of Facial Hemiatrophy is being reported for its rarity and clinical interest
Progressive facial hemiatrophy (PFH) is a ubiquitous disease, characterized by hyperpigmentation of ...
Progressive facial hemiatrophy (PFH) is a ubiquitous disease, characterized by hyperpigmentation of ...
Facial hemihypertrophy and facial hemiatrophy are rare developmental anomalies. These conditions are...
Introduction: The Parry Romberg syndrome (PRS) is a mosaic disease of unknown aetiology which mostly...
Progressive facial hemiatrophy (PFH) is a rare condition characterized by the slow, progressive appe...
Hemifacial hyperplasia (HFH) is characterized by an increase in volume of all affected tissues of ha...
association with antibodies to double-stranded DNA Sir, The report of Dr Adebajo and colleagues &apo...
© 2020 International Association of Oral and Maxillofacial SurgeonsUnilateral condylar hyperplasia (...
A 52-year-old man presented with left hemifacial at-rophy (figure 1) beginning at age 25. There were...
SUMMARY A case of a 28-year-old Caucasian female with progressive hemifacial atrophy and atrophy of ...
A case report of hemifacial atrophy is presented in this paper. It is also known as Parry-Romberg sy...
A lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, ma...
An asymmetric variation of facial structures is commonly seen in the general population. Hemimandibu...
Progressive Hemifacial atrophy (Parry-Romberg disease) is a rare condition affecting the face. It co...
A case of Facial Hemiatrophy is being reported for its rarity and clinical interest
Progressive facial hemiatrophy (PFH) is a ubiquitous disease, characterized by hyperpigmentation of ...
Progressive facial hemiatrophy (PFH) is a ubiquitous disease, characterized by hyperpigmentation of ...
Facial hemihypertrophy and facial hemiatrophy are rare developmental anomalies. These conditions are...
Introduction: The Parry Romberg syndrome (PRS) is a mosaic disease of unknown aetiology which mostly...
Progressive facial hemiatrophy (PFH) is a rare condition characterized by the slow, progressive appe...
Hemifacial hyperplasia (HFH) is characterized by an increase in volume of all affected tissues of ha...
association with antibodies to double-stranded DNA Sir, The report of Dr Adebajo and colleagues &apo...
© 2020 International Association of Oral and Maxillofacial SurgeonsUnilateral condylar hyperplasia (...
A 52-year-old man presented with left hemifacial at-rophy (figure 1) beginning at age 25. There were...
SUMMARY A case of a 28-year-old Caucasian female with progressive hemifacial atrophy and atrophy of ...
A case report of hemifacial atrophy is presented in this paper. It is also known as Parry-Romberg sy...
A lot of diseases, including lupus profundus, morphea, lipodystrophy, and Parry-Romberg syndrome, ma...
An asymmetric variation of facial structures is commonly seen in the general population. Hemimandibu...
Progressive Hemifacial atrophy (Parry-Romberg disease) is a rare condition affecting the face. It co...
A case of Facial Hemiatrophy is being reported for its rarity and clinical interest